GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » ROE %

Braxia Scientific (XCNQ:BRAX) ROE % : -4,293.49% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Braxia Scientific's annualized net income for the quarter that ended in Dec. 2023 was C$-3.63 Mil. Braxia Scientific's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was C$0.08 Mil. Therefore, Braxia Scientific's annualized ROE % for the quarter that ended in Dec. 2023 was -4,293.49%.

The historical rank and industry rank for Braxia Scientific's ROE % or its related term are showing as below:

XCNQ:BRAX' s ROE % Range Over the Past 10 Years
Min: -559.02   Med: -248.71   Max: -97.65
Current: -458.31

During the past 3 years, Braxia Scientific's highest ROE % was -97.65%. The lowest was -559.02%. And the median was -248.71%.

XCNQ:BRAX's ROE % is ranked worse than
95% of 1360 companies
in the Biotechnology industry
Industry Median: -43.445 vs XCNQ:BRAX: -458.31

Braxia Scientific ROE % Historical Data

The historical data trend for Braxia Scientific's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braxia Scientific ROE % Chart

Braxia Scientific Annual Data
Trend Mar21 Mar22 Mar23
ROE %
-559.02 -97.65 -248.71

Braxia Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -94.50 -641.91 -266.33 -163.11 -4,293.49

Competitive Comparison of Braxia Scientific's ROE %

For the Biotechnology subindustry, Braxia Scientific's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Braxia Scientific's ROE % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Braxia Scientific's ROE % distribution charts can be found below:

* The bar in red indicates where Braxia Scientific's ROE % falls into.



Braxia Scientific ROE % Calculation

Braxia Scientific's annualized ROE % for the fiscal year that ended in Mar. 2023 is calculated as

ROE %=Net Income (A: Mar. 2023 )/( (Total Stockholders Equity (A: Mar. 2022 )+Total Stockholders Equity (A: Mar. 2023 ))/ count )
=-13.142/( (8.963+1.605)/ 2 )
=-13.142/5.284
=-248.71 %

Braxia Scientific's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-3.628/( (0.535+-0.366)/ 2 )
=-3.628/0.0845
=-4,293.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Braxia Scientific  (XCNQ:BRAX) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-3.628/0.0845
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-3.628 / 1.968)*(1.968 / 2.625)*(2.625 / 0.0845)
=Net Margin %*Asset Turnover*Equity Multiplier
=-184.35 %*0.7497*31.0651
=ROA %*Equity Multiplier
=-138.21 %*31.0651
=-4,293.49 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-3.628/0.0845
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-3.628 / -3.628) * (-3.628 / -3.428) * (-3.428 / 1.968) * (1.968 / 2.625) * (2.625 / 0.0845)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 1.0583 * -174.19 % * 0.7497 * 31.0651
=-4,293.49 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Braxia Scientific ROE % Related Terms

Thank you for viewing the detailed overview of Braxia Scientific's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Braxia Scientific (XCNQ:BRAX) Business Description

Traded in Other Exchanges
Address
700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific (XCNQ:BRAX) Headlines

No Headlines